Technology can work and still fail to create value.
Vahana Labs helps healthcare leaders close the gap between technology capability and repeatable value, whether they are building the technology or putting it to work.
18+ years · 30+ regulated products · AI, diagnostics, digital health and clinical technology
One conversion problem. Two sides of the market.
Building healthcare technology
Your product performs. The market is interested. But authorization, pilots and customer enthusiasm have not become paid, routine, repeatable use.
For healthtech companies →Putting technology to work
You have invested in AI, automation or technology platforms. But deployment has not reliably become capacity, margin, quality, speed or better economics.
For healthcare organizations & investors →The technology is rarely the whole problem.
Value gets trapped in the decisions around it.
The proof doesn't answer the decision.
The product performs, but the evidence does not tell a buyer, executive or investor what to do.
The workflow absorbs the gain.
Technology saves time in one step while review, handoffs or downstream work consume the benefit somewhere else.
Interest never becomes commitment.
There is a champion, pilot or internal sponsor, but no economic owner willing and able to act.
Deployment doesn't become adoption.
The system goes live without becoming the normal way work gets done.
Scale creates complexity instead of leverage.
Each customer, site, market or workflow adds another exception.
No one owns the consequential decision.
Product, clinical, regulatory, security, finance and operations can each make rational local decisions while the overall economics fail.
Bring us the decision your team keeps circling.
Most of this work starts at one of these moments.
Two ways we work on the conversion problem
AI & Technology Value Creation
Determine where technology should create operating value, why that value is not appearing, and what must change to capture it.
Explore AI & Technology Value Creation →Regulated Product Commercialization
Turn technical performance and market interest into cleanly paid, routine, evidence-supported use.
Explore Healthtech Commercialization →Both sides of enterprise scrutiny
The vendor trying to clear the review, and the executive whose signature authorized the technology's use.
Vahana Labs is led by Arvita Tripati, who has spent nearly two decades building regulated healthcare products and making the enterprise decisions required to put them into use.
More on the backgroundAttributed to an accelerated regulated launch.
An AI-enabled regulated workflow — then the human review around it had to change before the speed became capacity.
Regulated products through FDA and into enterprise healthcare environments.
Find where the value is getting trapped.
If the technology is working but the expected business, clinical or operating value is not appearing, that is the conversation Vahana is built for.
Talk through the decision →